发明授权
EP1863795B1 SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS 有权
取代的三唑催产素

  • 专利标题: SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS
  • 专利标题(中): 取代的三唑催产素
  • 申请号: EP06710566.8
    申请日: 2006-03-08
  • 公开(公告)号: EP1863795B1
    公开(公告)日: 2008-10-29
  • 发明人: CALABRESE, Andrew, Antony
  • 申请人: Pfizer Limited
  • 申请人地址: Ramsgate Road Sandwich, Kent CT13 9NJ GB
  • 专利权人: Pfizer Limited
  • 当前专利权人: Pfizer Limited
  • 当前专利权人地址: Ramsgate Road Sandwich, Kent CT13 9NJ GB
  • 代理机构: Nevant, Marc
  • 优先权: US664091P 20050321
  • 国际公布: WO2006100557 20060928
  • 主分类号: C07D401/14
  • IPC分类号: C07D401/14 A61K31/497 A61P5/10
SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS
摘要:
The present invention relates to a class of substituted triazoles of formula (I) with activity as oxytocin antagonists, uses thereof, processes for the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction, particularly premature ejaculation (P.E.).
公开/授权文献
信息查询
0/0